229 related articles for article (PubMed ID: 33221760)
21. Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma.
Go H; Jang JY; Kim CW; Huh J; Kim PJ; Jeon YK
Leuk Lymphoma; 2020 Jan; 61(1):66-74. PubMed ID: 31441360
[TBL] [Abstract][Full Text] [Related]
22. Molecular underpinning of extranodal NK/T-cell lymphoma.
Huang Y; de Leval L; Gaulard P
Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
[TBL] [Abstract][Full Text] [Related]
23. T-cell dysfunction in natural killer/T-cell lymphoma.
Feng X; Meng M; Li H; Gao Y; Song W; Di R; Li Z; Zhang X; Zhang M
Oncoimmunology; 2023; 12(1):2212532. PubMed ID: 37250921
[TBL] [Abstract][Full Text] [Related]
24. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
[TBL] [Abstract][Full Text] [Related]
29. The aberrant activation of Wnt pathway caused by β-catenin mutation and its prognostic significance in NK/T-cell lymphoma.
Qin BB; Tang DF; Ni ML; Gao W; Zhang MZ
Neoplasma; 2019 Jan; 66(1):20-27. PubMed ID: 30509083
[TBL] [Abstract][Full Text] [Related]
30. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
[TBL] [Abstract][Full Text] [Related]
31. Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W; Zhang M
Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
[TBL] [Abstract][Full Text] [Related]
32. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.
Li Z; Xia Y; Feng LN; Chen JR; Li HM; Cui J; Cai QQ; Sim KS; Nairismägi ML; Laurensia Y; Meah WY; Liu WS; Guo YM; Chen LZ; Feng QS; Pang CP; Chen LJ; Chew SH; Ebstein RP; Foo JN; Liu J; Ha J; Khoo LP; Chin ST; Zeng YX; Aung T; Chowbay B; Diong CP; Zhang F; Liu YH; Tang T; Tao M; Quek R; Mohamad F; Tan SY; Teh BT; Ng SB; Chng WJ; Ong CK; Okada Y; Raychaudhuri S; Lim ST; Tan W; Peng RJ; Khor CC; Bei JX
Lancet Oncol; 2016 Sep; 17(9):1240-7. PubMed ID: 27470079
[TBL] [Abstract][Full Text] [Related]
33. Advances in multiple omics of natural-killer/T cell lymphoma.
Xiong J; Zhao WL
J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
[TBL] [Abstract][Full Text] [Related]
34. IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4.
Ni M; Qin B; Xie L; Zhang X; Yang J; Lv H; Yang M; Zhang M
Biomed Res Int; 2018; 2018():2606834. PubMed ID: 30643796
[TBL] [Abstract][Full Text] [Related]
35. Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma.
Liu S; Li C; Xin P; Zheng Y; Peng Q; Xu Y; Luo Y; Wu Y; Zhu X
Med Sci Monit; 2019 Nov; 25():8579-8586. PubMed ID: 31724562
[TBL] [Abstract][Full Text] [Related]
36. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
[TBL] [Abstract][Full Text] [Related]
37. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.
Baytak E; Gong Q; Akman B; Yuan H; Chan WC; Küçük C
Tumour Biol; 2017 May; 39(5):1010428317701648. PubMed ID: 28468592
[TBL] [Abstract][Full Text] [Related]
38. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
Lin N; Ku W; Song Y; Zhu J; Lu Z
Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
[TBL] [Abstract][Full Text] [Related]
39. Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion.
Han L; Schubert C; Köhler J; Schemionek M; Isfort S; Brümmendorf TH; Koschmieder S; Chatain N
J Hematol Oncol; 2016 May; 9(1):45. PubMed ID: 27177927
[TBL] [Abstract][Full Text] [Related]
40. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
